BD1 just hired a CEO paid in 5c options, who presumably did plenty of due diligence before joining. It is still very early stage. It is having it's lung cancer blood test verified by a US company called Meso Scale, and if it checks out well then share price it should do well from here. There is supply at 4c at the moment.
Daytraders After Market Lounge 8th Nov, page-36
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)